Long lasting anti-adrenergic effect of 7-oxo-prostacyclin in the heart: a cycloheximide sensitive increase of phosphodiesterase isoform I and IV activities.

Evidence is accumulating that 7-oxo-prostacyclin (7-oxo-PGI2) induces a delayed indirect anti-adrenergic and cytoprotective effect on the myocardium, the mechanism of which is still unclear. To demonstrate that a single application of 7-oxo-PGI2 (50 micrograms/kg i.m.

In vitro effects of reactive O2 species on the beta-receptor-adenylyl cyclase system.

The irreversible loss of activity of the sarcolemma-localized beta-receptor-adenylyl cyclase system (beta-RAS) in myocardial ischemia is a well documented phenomenon. Alterations in the sarcolemma (SL) induced by reactive O2 species could be responsible for this loss. Therefore the influence of oxidation of SH-groups and lipid peroxidation induced by Fe2+/Vit.

G protein function in the ischaemic myocardium.

The activity of adenylyl cyclase (AC) is controlled by its interaction with receptor-regulated G proteins. The efficiency to form cyclic AMP is strongly influenced by the amount, the subspecies and function of these regulatory proteins. An impairment of AC function has been shown to occur in sarcolemmal preparations (SL) of hearts exposed to either local or global ischaemia.

Immunocytochemical localization of G-proteins (alpha subunits) in rat heart tissue.

The subcellular localization of peptide antibodies against G-protein alpha subunits was studied by the indirect immunogold technique with Lowicryl K4M embedded rat cardiac tissue. Two antibodies were used. The alpha common peptide antibody recognizes the alpha subunits of Gs, Gi and Go.

Free radical-induced damage of cardiac sarcolemma (SL) and activity loss of beta-receptor adenylate cyclase system (beta-RAS). A comparison of the time courses.

In vitro studies have demonstrated that free radicals generated by Fe2+/Vit. C alter the beta-RAS function. SH-oxidation, peroxidation of sarcolemmal lipids and reaction of aldehydes (formed by lipid peroxidation) with the beta-RAS may contribute to this effect.

Responsiveness of cardiac adenylate cyclase in the normal and ischemic myocardium. Role of oxygen free radicals.

Cyclic AMP has been shown to play a significant regulatory role in a number of myocardial cell functions. The cAMP-forming adenylate cyclase complex is localized in the sarcolemmal membrane which is the major site of lipid peroxidation by oxygen-derived free radicals known to be increased in the ischemic myocardium. Adenylate cyclase function was found to be depressed in the ischemic myocardium but the specific biochemical mechanism responsible for this effect is still unknown.

Cytochemical localization of adenylate cyclase activity in heart tissue with cerium.

Adenylate cyclase (AC) activity showed a doses depending inactivation of the basal activity and of the sodium fluoride stimulation by cerium in homogenates of unfixed and fixed guinea pig hearts. The isoproterenol and guanine nucleotide stimulation was not more than two times of the basal activity in glutaraldehyde-prefixed heart homogenates in the presence of 2 mmol/l CeCl3. The inactivation of the AC (activity) by cerium was less than in the presence of lead.

Developmental changes of Ca++ transport systems in chick heart.

Sarcolemma (SL) Na+/Ca++ exchange, binding of the Ca++ channel antagonist [3H]nitrendipine and sarcoplasmic reticulum (SR) Ca++ uptake were studied in crude membranes from developing chick heart. Energy-linked Ca++ uptake of mitochondria (MT) was measured in tissue homogenates. When reckoned per unit of heart mass Na+/Ca++ exchange increases linearly (20-fold) from embryonic day 4 to postnatal day 10.

Signal transfer in cardiac muscle. Alteration of the beta-adrenoceptor adenylate cyclase system in the hypertrophied myocardium.

The beta-adrenoceptor adenylate cyclase complex (beta ACR), located in the sarcolemmal membrane, is one of the most effective signal transduction systems regulating function and metabolism of heart muscle primarily via cyclic AMP. It is thought to play an important role in adaptive mechanisms of the heart as to pressure load and stressful stimuli. Present knowledge about composition and function of beta ARC enable us to clear up which of the single components of this system contributes to pathophysiological alterations of heart function.

Comparative analysis of phospholamban phosphorylation in crude membranes of vertebrate hearts.

Phospholamban, a sarcoplasmic reticulum phosphoprotein, is present in the hearts of mammalian, avian, amphibian, and fish species. Phylogenetic changes are indicated by marked differences among species in cardiac phospholamban content and by the absence of Ca2+/calmodulin-dependent phospholamban phosphorylation at an early developmental stage.

Reversible inhibition of adenylate cyclase activity in the ischemic myocardium.

Adenylate cyclase (AC) function was studied in homogenate and particulate preparations of ischemic rat heart obtained from three models: anoxic-ischemic incubations, coronary artery ligation, and global low-flow perfusion of isolated hearts. Both basal activity and the function of AC measured in the presence of NaF (8 X 10(-3)M), Gpp(NH)p (10(-5)M), and L-(-)-isoprenaline (10(-8)-10(-4)M) were reduced to 50% of the control value in homogenates of hearts incubated under anoxic-ischemic conditions for 10 min. Comparable results were obtained with homogenates from the ischemic area 20 min after coronary artery ligation in anesthetized open-chest rats with artificial ventilation.

Early presence of phospholamban in developing a chick heart.

Phosphorylation of phospholamban and development of reticular Ca2+ transport were studied in crude membrane preparations of embryonic, newborn and adult chick heart. Maximal phosphorylation of phospholamban by added catalytic subunit of cyclic AMP-dependent protein kinase increases from embryonic day 4-15. It decreases with further development.

Stimulation of rat and cat heart adenylate cyclase by triiodothyronine in the presence of 5'-guanylylimidodiphosphate.

Adenylate cyclase activity in particulate preparations from the myocardium of rats and cats was unaffected by 3,3',5-triiodo-L-thyronine (L-T3) added in the absence of, or together with, 5-guanylylimidodiphosphate (Gpp(NH)p), a potent activator of the enzyme. Preincubation of the heart particles with Gpp(NH)p made the cyclase sensitive to L-T3 which then caused, in concentrations of 10(-8) M and higher, additional increases in enzyme activity up to about 50 per cent above the Gpp(NH)p-stimulated level. Similar effects after (GPP(NH)p treatment were produced by low concentrations of 3,3',5'-triiodo-L-thyronine (reverse T3) and 3,3',5-triiodo-D-thyronine, whereas diiodo-tyrosine, 3,5-diiodo-L-thyronine, and 3'-isopropyl-3,5-diiodo-L-thyronine were without significant effect.